Marchex R&D Spending Growth & History (MCHX)
Marchex's r&d spending was $9.7M for fiscal 2025.
View full Marchex company overviewMarchex annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9.7M | −$2.7M | −21.48% |
| 2024 | 2024-12-31 | $12.4M | −$2.9M | −19.15% |
| 2023 | 2023-12-31 | $15.4M | $1.0M | +6.97% |
| 2022 | 2022-12-31 | $14.4M | −$1.8M | −10.90% |
| 2021 | 2021-12-31 | $16.1M | −$4.9M | −23.28% |
| 2020 | 2020-12-31 | $21.0M | $3.1M | +17.46% |
| 2019 | 2019-12-31 | $17.9M | $2.5M | +15.92% |
| 2018 | 2018-12-31 | $15.4M | −$2.7M | −14.76% |
| 2017 | 2017-12-31 | $18.1M | −$10.4M | −36.39% |
| 2016 | 2016-12-31 | $28.4M | −$2.6M | −8.41% |
| 2015 | 2015-12-31 | $31.1M | $1.5M | +5.06% |
| 2014 | 2014-12-31 | $29.6M | $2.2M | +8.16% |
| 2013 | 2013-12-31 | $27.3M | $4.1M | +17.81% |
| 2012 | 2012-12-31 | $23.2M | $597,000 | +2.64% |
| 2011 | 2011-12-31 | $22.6M | $5.8M | +34.51% |
| 2010 | 2010-12-31 | $16.8M | $2.3M | +16.07% |
| 2009 | 2009-12-31 | $14.5M | — | — |
Marchex quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.0M | −$510,000 | −20.39% |
| Q1 2026 | 2026-03-31 | $2.4M | −$264,000 | −9.88% |
| Q4 2025 | 2025-12-31 | $2.2M | −$635,000 | −22.36% |
| Q3 2025 | 2025-09-30 | $2.4M | −$736,000 | −23.70% |
| Q2 2025 | 2025-06-30 | $2.5M | −$722,000 | −22.40% |
| Q1 2025 | 2025-03-31 | $2.7M | −$574,000 | −17.69% |
| Q4 2024 | 2024-12-31 | $2.8M | −$313,000 | −9.93% |
| Q3 2024 | 2024-09-30 | $3.1M | −$836,000 | −21.21% |
| Q2 2024 | 2024-06-30 | $3.2M | −$873,000 | −21.31% |
| Q1 2024 | 2024-03-31 | $3.2M | −$919,000 | −22.07% |
| Q4 2023 | 2023-12-31 | $3.2M | −$687,000 | −17.89% |
| Q3 2023 | 2023-09-30 | $3.9M | $418,000 | +11.86% |
| Q2 2023 | 2023-06-30 | $4.1M | $565,000 | +16.00% |
| Q1 2023 | 2023-03-31 | $4.2M | $704,000 | +20.35% |
| Q4 2022 | 2022-12-31 | $3.8M | $1.0M | +36.03% |
| Q3 2022 | 2022-09-30 | $3.5M | $346,000 | +10.89% |
| Q2 2022 | 2022-06-30 | $3.5M | −$1.3M | −26.27% |
| Q1 2022 | 2022-03-31 | $3.5M | −$1.9M | −34.99% |
| Q4 2021 | 2021-12-31 | $2.8M | −$2.3M | −45.39% |
| Q3 2021 | 2021-09-30 | $3.2M | −$2.0M | −38.49% |
| Q2 2021 | 2021-06-30 | $4.8M | −$518,000 | −9.76% |
| Q1 2021 | 2021-03-31 | $5.3M | −$36,000 | −0.67% |
| Q4 2020 | 2020-12-31 | $5.2M | $2.0M | +63.01% |
| Q3 2020 | 2020-09-30 | $5.2M | $32,000 | +0.62% |
| Q2 2020 | 2020-06-30 | $5.3M | $302,000 | +6.03% |
| Q1 2020 | 2020-03-31 | $5.4M | $790,000 | +17.29% |
| Q4 2019 | 2019-12-31 | $3.2M | −$870,000 | −21.53% |
| Q3 2019 | 2019-09-30 | $5.1M | $1.3M | +33.00% |
| Q2 2019 | 2019-06-30 | $5.0M | $1.1M | +29.23% |
| Q1 2019 | 2019-03-31 | $4.6M | $920,000 | +25.22% |
| Q4 2018 | 2018-12-31 | $4.0M | −$244,000 | −5.69% |
| Q3 2018 | 2018-09-30 | $3.9M | −$395,000 | −9.28% |
| Q2 2018 | 2018-06-30 | $3.9M | −$410,000 | −9.57% |
| Q1 2018 | 2018-03-31 | $3.6M | −$1.6M | −30.78% |
| Q4 2017 | 2017-12-31 | $4.3M | −$2.3M | −34.95% |
| Q3 2017 | 2017-09-30 | $4.3M | −$2.6M | −37.70% |
| Q2 2017 | 2017-06-30 | $4.3M | −$3.3M | −43.31% |
| Q1 2017 | 2017-03-31 | $5.3M | −$2.2M | −29.47% |
| Q4 2016 | 2016-12-31 | $6.6M | −$862,000 | −11.57% |
| Q3 2016 | 2016-09-30 | $6.8M | −$937,000 | −12.06% |
| Q2 2016 | 2016-06-30 | $7.6M | −$592,000 | −7.27% |
| Q1 2016 | 2016-03-31 | $7.5M | −$221,000 | −2.87% |
| Q4 2015 | 2015-12-31 | $7.4M | $487,000 | +7.00% |
| Q3 2015 | 2015-09-30 | $7.8M | $188,000 | +2.48% |
| Q2 2015 | 2015-06-30 | $8.1M | $689,000 | +9.24% |
| Q1 2015 | 2015-03-31 | $7.7M | $133,000 | +1.76% |
| Q4 2014 | 2014-12-31 | $7.0M | $216,000 | +3.20% |
| Q3 2014 | 2014-09-30 | $7.6M | $748,000 | +10.95% |
| Q2 2014 | 2014-06-30 | $7.5M | $514,000 | +7.40% |
| Q1 2014 | 2014-03-31 | $7.6M | $752,000 | +11.05% |
| Q4 2013 | 2013-12-31 | $6.7M | $884,000 | +15.08% |
| Q3 2013 | 2013-09-30 | $6.8M | $1.3M | +24.01% |
| Q2 2013 | 2013-06-30 | $6.9M | $1.1M | +19.70% |
| Q1 2013 | 2013-03-31 | $6.8M | $781,000 | +12.96% |
| Q4 2012 | 2012-12-31 | $5.9M | $217,000 | +3.84% |
| Q3 2012 | 2012-09-30 | $5.5M | −$622,000 | −10.14% |
| Q2 2012 | 2012-06-30 | $5.8M | −$136,000 | −2.29% |
| Q1 2012 | 2012-03-31 | $6.0M | $1.1M | +23.28% |
| Q4 2011 | 2011-12-31 | $5.6M | — | — |
| Q3 2011 | 2011-09-30 | $6.1M | $1.9M | +46.23% |
| Q2 2011 | 2011-06-30 | $5.9M | $1.6M | +37.23% |
| Q1 2011 | 2011-03-31 | $4.9M | — | — |
| Q3 2010 | 2010-09-30 | $4.2M | — | — |
| Q2 2010 | 2010-06-30 | $4.3M | — | — |
Marchex r&d spending trends
Over the last five fiscal years, Marchex's r&d spending decreased from $21.0M to $9.7M, a change of −$11.3M. The latest reported quarter, Q2 2026, shows $2.0M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Marchex source filings ↗